|
FDA
approves Vioxx for acute treatment of migraine in adults
April 1, 2004 -- Merck’s once-daily arthritis and
pain medicine is the first and only COX-2 specific inhibitor
approved to relieve migraine pain and associated migraine
symptom. more...
FDA
approves Zyprexa IntraMuscular for faster control of acute
agitation
March 30, 2004 -- If ongoing Zyprexa therapy is needed,
physicians may transition patients with schizophrenia and
bipolar mania from Zyprexa IntraMuscular to oral Zyprexa
as soon as clinically appropriate. more...
FDA
details risk management regime for generic oxycodone hydrochloride
ER tablets...
[March 23, 2004]
FDA
advisory requests stronger patient monitoring warnings on
10 antidepressant drugs... [March 22, 2004]
Cancer
research finding: Positive side-effect of Xenical inhibits
prostate tumor growth...
March 15, 2004 -- Experiments in mice confirm orlistat has
no effect on normal prostate cells. more...
Study:
Breast cancer patients switched from tamoxifen to Aromasin
more likely to remain cancer-free... [March 10, 2004]
Acomplia
(rimonabant) study: smoking, obesity -- one pill to treat
them both?... [March 9, 2004]
Sensipar
approved -- first-in-class treatment for secondary hyperparathyroidism
in dialysis patients... [March 8, 2004]
|
